A Simplified, Fully Defined Differentiation Scheme for Producing Blood-Brain Barrier Endothelial Cells from Human iPSCs

DOI: 10.1016/j.stemcr.2019.05.008

Authors: Emma H. Neal; Nicholas A. Marinelli; Yajuan Shi; P. Mason McClatchey; Kylie M. Balotin; Dalton R. Gullett; Kameron A. Hagerla; Aaron B. Bowman; Kevin C. Ess; John P. Wikswo; Ethan S. Lippmann

Step 1: iPSC/ESC maintainance

day 0 ~ 1

culture “adherent” human PSC in “E8” for “1” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “1” days.

concentrationunit
Y276321.0e-5mol/l

Step 2: Primitive streak 1

day 1 ~ 2

culture “adherent” human PSC in “E6 medium” for “1” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should be changed once in “1” days.

Step 3: endothelial 1

day 2 ~ 4

culture “adherent” human PSC in “hESFM” for “2” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “2” days.

concentrationunit
B27——
FGF——
retinoic acid——
N2——
ITS——
PDS——

Ideally, “EC” should express “occludin”, “claudin-5”, “CDH5”, “GLUT-1”, “PECAM1”, “P-glycoprotein”, “MRP” at the end of culture.

Step 4: endothelial 2

day 4 ~ 5

culture “adherent” human PSC in “hESFM” for “1” days. For ECM, use “collagen IV/fibronectin” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “1” days.

concentrationunit
FGF——
retinoic acid——
B27——
N2——
ITS——
PDS——